Breaking News

You are here » Indian-Commodity  :  Commodities  :  Jeera  :  Jeera futures decline despite lower arrivals

04-May2018

Jeera futures decline despite lower arrivals

Jeera futures declined on NCDEX as traders locked-in gains at prevailing higher levels amid muted demand in the spot market. Lower arrivals from growing regions failed to increase demand.

The contract for May delivery was trading at Rs 15650.00, down by 0.51 % or Rs 80.00 from its previous closing of Rs 15730.00. The open interest of the contract stood at 4638 lots.

The contract for June delivery was trading at Rs 15580.00, down by 0.73 % or Rs 115.00 from its previous closing of Rs 15695.00. The open interest of the contract stood at 4167 lots on NCDEX.


Related News

View all news

Jeera futures trade lower on NCDEX

Jeera futures traded lower on NCDEX, as market players liquidated their holdings on anticipation of rise in production amid reports of higher sowing of cumin in Gujarat and Rajasthan. However, steady domestic......

Jeera futures trade higher on lower arrivals

Jeera futures traded higher on NCDEX, with concern that cumin yields may dip in coming season amid reports of deficient rainfall in key producing region of Gujarat like Saurashtra and Kutch. As per reports,......

Jeera futures surge on pick up in demand

Jeera futures surged on NCDEX, due to fresh positions built up, driven by pick-up in demand from stockists and overseas enquiries. Besides, tight stock positions following restricted arrivals from the......

Top News

View all news

RPP Infra Projects bags orders worth Rs 62.90 crore from BHEL

RPP Infra Projects has bagged orders from Bharat Heavy Electricals (BHEL), Chennai for worth of Rs 62.90 crore. The first order is for providing civil works of Boiler, Mill and Bunker, ESP area of unit......

Glenmark gets tentative ANDA approval for Abiraterone Acetate Tablets

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Abiraterone Acetate Tablets USP, 250 mg, a generic......

HDFC Standard Life Insurance reports 18% rise in Q3 net profit

HDFC Standard Life Insurance has reported results for third quarter ended December 31, 2018. The company has reported a rise of 18.48% in its net profit at Rs 245.63 crore for the quarter under review......